Géraldine Cizeron-Clairac
Impact in
- Neurology top 5%
- Myasthenia Gravis and Thymoma
- Peripheral Neuropathies and Disorders
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Myasthenia Gravis and Thymoma 7
- Peripheral Neuropathies and Disorders 2
-
- Pituitary Gland Disorders and Treatments 3
- Adrenal Hormones and Disorders 2
- Co-authors
- Sonia Berrih‐Aknin (8 shared papers)Rozen Le Panse (8 shared papers)Jacky Bismuth (7 shared papers)Rosette Lidereau (8 shared papers)Sophie Vacher (8 shared papers)Ivan Bièche (8 shared papers)A. Susini (5 shared papers)Frédérique Truffault (4 shared papers)
- Journals
- International Journal of Cancer (2 papers)Blood (2 papers)Journal of Neuroimmunology (1 paper)Molecular Cancer (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- FranceCzechiaUnited States
In The Last Decade
Géraldine Cizeron-Clairac
16 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 77
- Neurology 350
- Cancer Research 279
- Endocrinology, Diabetes and Metabolism 140
- Immunology 169
- Oncology 170
Countries citing papers authored by Géraldine Cizeron-Clairac
This map shows the geographic impact of Géraldine Cizeron-Clairac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Cizeron-Clairac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Cizeron-Clairac more than expected).
Fields of papers citing papers by Géraldine Cizeron-Clairac
This network shows the impact of papers produced by Géraldine Cizeron-Clairac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Cizeron-Clairac. The network helps show where Géraldine Cizeron-Clairac may publish in the future.
Co-authors
The 25 scholars most cited alongside Géraldine Cizeron-Clairac, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 164 | |
| 2 | 2012 | 154 | |
| 3 | 2012 | 145 | |
| 4 | 2006 | 131 | |
| 5 | 2009 | 63 | |
| 6 | 2013 | 63 | |
| 7 | 2010 | 63 | |
| 8 | 2006 | 61 | |
| 9 | 2011 | 58 | |
| 10 | 2010 | 55 | |
| 11 | 2015 | 48 | |
| 12 | 2008 | 47 | |
| 13 | 2007 | 33 | |
| 14 | 2010 | 30 | |
| 15 | 2012 | 27 | |
| 16 | 2008 | 24 |
About Géraldine Cizeron-Clairac
Géraldine Cizeron-Clairac is a scholar working on Neurology, Endocrinology, Diabetes and Metabolism, Molecular Biology, Oncology and Immunology, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include Myasthenia Gravis and Thymoma (7 papers), Pituitary Gland Disorders and Treatments (3 papers), Chemokine receptors and signaling (2 papers), T-cell and B-cell Immunology (2 papers), Peripheral Neuropathies and Disorders (2 papers), Circular RNAs in diseases (2 papers), MicroRNA in disease regulation (2 papers) and Adrenal Hormones and Disorders (2 papers). The work is most often cited by research in Neurology (350 citations), Cancer Research (279 citations), Endocrinology, Diabetes and Metabolism (140 citations), Immunology (169 citations) and Oncology (170 citations). Géraldine Cizeron-Clairac has collaborated with scholars based in France, Czechia and United States. Frequent co-authors include Sonia Berrih‐Aknin, Rozen Le Panse, Jacky Bismuth, Rosette Lidereau, Sophie Vacher, Ivan Bièche, A. Susini, Frédérique Truffault, Magdalena Čížková and Catherine Andrieu. Their work appears in journals such as International Journal of Cancer, Blood, Journal of Neuroimmunology, Molecular Cancer and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.